Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting?

Hiroaki Sakamoto1, Yasunori Watanabe, Masataka Satou

  • 1Department of Cardiovascular Surgery, Hitachi General Hospital, Hitachi, Ibaraki, Japan. sakamotoh@md.tsukuba.ac.jp

Insights

Preoperative statin therapy significantly reduced the incidence of postoperative atrial fibrillation (AF) following coronary artery bypass grafting (CABG). This finding suggests statins may be beneficial in preventing AF after cardiac surgery.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Statins possess pleiotropic effects, including anti-inflammatory and potential atrial fibrillation (AF) preventive properties.
  • Postoperative AF is a common complication after coronary artery bypass grafting (CABG).

Purpose of the Study:

  • To evaluate the efficacy of preoperative statin therapy in mitigating the risk of AF subsequent to CABG.
  • To identify predictors of AF development after CABG.

Main Methods:

  • A retrospective analysis of 221 patients undergoing CABG between 2004 and 2007.
  • Patients were stratified into preoperative statin (n=77) and non-statin (n=126) groups, and into postoperative AF (n=54) and non-AF (n=149) groups.
  • Multivariate analysis was employed to determine independent predictors of postoperative AF.

Main Results:

  • The overall incidence of postoperative AF was 26%.
  • Patients receiving preoperative statin therapy exhibited a significantly lower incidence of postoperative AF (16%) compared to the non-statin group (33%, p=0.005).
  • Independent predictors for AF development included preoperative statin use (OR 0.327, p=0.05) and age (OR 1.058, p=0.035).

Conclusions:

  • Preoperative statin therapy appears to be an effective strategy for reducing the incidence of AF after CABG.
  • Statin therapy may play a protective role against the development of atrial fibrillation in the post-cardiac surgery setting.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...